慢性支气管炎呼吸内科规范治疗的效果  

Effects of respiratory medicine standard treatment for chronic bronchitis

作　　者：刘云英 LIU Yun-ying(the Hospital of Lantian County,Xi'an 710500,China)

机构地区：[1]蓝田县医院,陕西西安710500

出　　处：《临床医学研究与实践》2018年第9期42-43,共2页Clinical Research and Practice

摘　　要：目的分析慢性支气管炎呼吸内科规范治疗的效果。方法自我院收治的慢性支气管炎患者中筛选符合纳入排除标准的80例纳入研究范围,以随机数字法将其分为观察组与对照组,每组40例。对照组给予常规治疗,观察组进行内科规范化治疗。对比两组疗效、病原菌清除情况及不良反应发生率。结果观察组临床控制率(50.00%)、总有效率(90.00%)、病原菌清除率(92.30%)均高于对照组(25.00%、72.50%、68.00%),不良反应总发生率(5.00%)显著低于对照组(20.00%),差异均有统计学意义(P<0.05)。结论慢性支气管炎呼吸内科规范治疗可通过对抗感染药物的合理运用,达到有效杀灭病原菌的目的,获得最大的治疗获益。O b jective To analyze the effects of respiratory medicine standard treatment for chronic bronchitis.M eth o d s Eighty cases of patients with chronic bronchitis in our hospital were selected according to the inclusion and exclusion criteria,and were divided into the observation group and the control group according to random number table method,with 40 cases in each group.The control group was given routine treatment,and the observation group was given the medicine standard treatment.The efficacy,pathogen clearance and the incidence rate of adverse reactions were compared between the two groups.R esu lts The clinical control rate,total effective rate and pathogen clearance rate(50.00%,90.00%and 92.30%)in the observation group were higher than those in the control group(25.00%,72.50%and 68.00%),and the total incidence rate of adverse reactions in the observation group(5.00%)was significantly lower than that in the control group(20.00%)(P<0.05).C on clu sion Respiratory medicine standard treatment for chronic bronchitis can achieve the purpose of effective killing of pathogens through the rational use of anti-infective drug,and obtaining the greatest benefit of treatment.

关 键 词：慢性支气管炎 呼吸内科规范治疗 细菌清除率 

分 类 号：R562.2[医药卫生—呼吸系统]